Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

FDA and Industry Take Action for a More Secure Drug Supply Chain

New identifiers and tracking requirements aim to block illegitimate products.
May 2, 2014

New identifiers and tracking requirements aim to block illegitimate products.

Demand for New Vaccines Spurs Innovation

New formulations and expanded vaccine production are encouraged.
May 2, 2014

New formulations and expanded vaccine production are encouraged.

FDA and Manufacturers Seek a More Secure Drug Supply Chain

New identifiers and tracking requirements aim to block illegitimate products.
Apr 2, 2014

New identifiers and tracking requirements aim to block illegitimate products.

Manufacturers Struggle with Breakthrough Drug Development

Accelerated testing and production create challenges in documenting product quality.
Mar 2, 2014

Accelerated testing and production create challenges in documenting product quality.

FDA Focuses on Drug Appearance and Attributes

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.
Feb 2, 2014

FDA urges manufacturers to examine how shape, size, and color may affect patient safety and enhance treatment adherence.

Metrics Sought to Ensure Drug Quality

Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.
Jan 2, 2014

Regulators work with manufacturers to improve systems for measuring product performance and manufacturing reliability.

Analyzing Nano Drugs

Dec 12, 2013

FDA details efforts to evaluate potential risks from use of nanomaterials in drug products and discuss analytical considerations, impact on stability, safety, and toxicology effects.

Super Oversight for Generics

Dec 12, 2013

OGD is under pressure to improve review operations.

Congress Revises Rules for Drug Compounding and Supply-Chain Security

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
Dec 4, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here